 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- || Nylexa (cysteamine IV) / NovaBiotics
Review, Journal: Educational Resource Review: Nylexa animation. (Pubmed Central) - Aug 20, 2021
No abstract available
- ||| Lynovex oral (cysteamine oral) / NovaBiotics
Trial completion: CARE-CF1: A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations (clinicaltrials.gov) - Jun 26, 2018
P2, N=91, Completed, Sponsor: NovaBiotics Ltd.
No abstract available Recruiting --> Completed
- || Lynovex oral (cysteamine oral) / NovaBiotics
Trial primary completion date: CARE-CF1: A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations (clinicaltrials.gov) - Dec 26, 2017
P2, N=120, Recruiting, Sponsor: NovaBiotics Ltd.
Recruiting --> Completed Trial primary completion date: Nov 2017 --> Feb 2018
- || Lynovex oral (cysteamine oral) / NovaBiotics
Trial primary completion date: CARE-CF1: A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations (clinicaltrials.gov) - Jul 25, 2017
P2, N=120, Recruiting, Sponsor: NovaBiotics Ltd.
Trial primary completion date: Nov 2017 --> Feb 2018 Trial primary completion date: Apr 2017 --> Nov 2017
- |||| Lynovex oral (cysteamine oral) / NovaBiotics
Enrollment open: CARE-CF1: A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations (clinicaltrials.gov) - Jan 20, 2017
P2, N=120, Recruiting, Sponsor: NovaBiotics Ltd.
Trial primary completion date: Apr 2017 --> Nov 2017 Not yet recruiting --> Recruiting
- ||||| Lynovex oral (cysteamine oral) / NovaBiotics
New P2 trial: CARE-CF1: A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations (clinicaltrials.gov) - Dec 22, 2016
P2, N=120, Not yet recruiting, Sponsor: NovaBiotics Ltd.